What You Should Know:
– HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch.
– HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared…
Continue Reading
(L to R) Dr Yola Jones of Seluna, Dr Ruth Hamilton, Dr Scott Black of Seluna, Prof Haytham Kubba, and Innes Taylor of Seluna (Credit: Martin Shields Photography)
Glasgow-based MedTech firm Seluna has launched…
Continue Reading
Millions of individuals worldwide suffer from retinal anomalies, which can lead to irreversible vision loss. However, the number of ophthalmologists is highly mismatched with the population base in China, especially in many rural and…
Continue Reading
This systematic review examines the cost-effectiveness, utility, and budget impact of clinical artificial intelligence (AI) interventions across diverse healthcare settings. Nineteen studies spanning oncology, cardiology, ophthalmology, and infectious diseases demonstrate that AI improves diagnostic…
Continue Reading
Many rare genetic diseases have recognizable facial phenotypes that serve as diagnostic clues. While Large Language Models (LLMs) have shown potential in healthcare, their application to rare genetic diseases still faces challenges like hallucination…
Continue Reading
Large language models (LLMs) have shown promising capabilities across diverse domains, yet their application to complex clinical prediction tasks remains limited. In this study, we present CARE-AD (Collaborative Analysis and Risk Evaluation for Alzheimer’s…
Continue Reading
Image Credit: Revealense
What You Should Know:
– ARC, the innovation arm of the world-renowned Sheba Medical Center, and Revealense, a creator of a neurological-AI engine, have announced a joint venture.
– The collaboration will focus on…
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
What You Should Know:
– Better Medicine, an AI-powered diagnostic startup for radiology, has secured nearly €6M ($6.89M) in total funding. The company recently raised €1M ($1.1M) in a pre-seed funding round led by Soulmates…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
